Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Online Training Recording

Course No. 22613

header-image

Speakers

Dr. Raphael Bar

Dr. Raphael Bar

BR Consulting

Dr. Thomas Fürst

Dr. Thomas Fürst

Boehringer Ingelheim

Objectives

This Live Online Training will give an overview of tools that a Qualified Person (QP), Quality Assurance personnel or a Product Manager/Manufacturer should have in order to evaluate the impact of excursions from the storage label instructions on the disposition of distributed shipments of pharmaceutical/biopharmaceutical products.

Background

The formal stability studies of pharmaceuticals and biopharmaceuticals are a well-established discipline and they are regularly conducted at precisely monitored conditions of temperature (within 2 °C) and of humidity (within 5% RH) under cGMP. However, the inevitable processes of shipping and distributing medicines from the manufacturer to wholesaler to warehouses to the end user via air, ship or car exposes often the shipments to temperatures and humidity different from the label storage conditions. For instance, how would you handle a shipment that was exposed to a varying temperature up to 61oC in the airport for an accumulated duration of several days? How would you evaluate the quality of a refrigerated injectable that was exposed to near zero or freezing temperatures for a few hours? Would you release or reject such a shipment which may cost hundreds of thousands of dollars?

Shipping/distribution of a medicine is considered a “mobile storage”. However, a temperature excursion outside the label instructions may also be considered a ‘trauma” inflicted on the medicine and this may impact the quality of the newly arrived shipments. But, the big question remains: how would that ‘trauma” affect the quality at the end of the declared shelf life of any pharmaceutical and of a biopharmaceutical in particular? Will the long-term impact lead to a “hidden OOS”? This training will address these aspects. In addition, the course also includes two case studies and a session with video presentations. Further, a set of Q&A sessions will follow the lectures. Thus, take advantage of this opportunity to pose your questions.

Target Group

This Live Online Training will be of significant value to
  •  Qualified Persons
  •  Quality Assurance personnel
  •  Pharmacists
  •  Project coordinators/product managers
  •  Stability testing personnel
  •  Stability program logistics personnel
  •  R&D personnel involved in product development

Date & Technical Requirements

To participate in an on demand training course or webinar, you do not need any software. The recordings are made available via a streaming server. In general, the recording is provided in MP4 format, which any PC (Microsoft Windows, Apple IOS) or tablet can easily display.

Timing and Duration:
When you register for the on demand Training course or webinar you can decide at what date you want to follow the training course online. For a 1-day training course you will have 2 days in which the stream is available (for 2-day training course 3 days and for a 3-day training course 4 days). Within in this timeframe you can start & stop the stream according to your needs.

In time before the scheduled date (your desired date) you will receive an e-mail from us with a link for direct participation as well as your log-in data.

Please be aware: The recording does not include the Q & A sessions.

Training Course Documentation and Certificate:
The presentation will be made available as PDF-files via download during the online training course. After the successful completion of the online training, you are able to download the certificate of attendance.

Programme

Overview of Stability Programs and Storage Statements
  • Stability studies and development phases
  • Long-term and accelerated storage conditions of new drug substances and products (EU, USA)
  • Stability storage programs for generic drugs (EU, USA)
  • Specific storage statements (EU, WHO, USP)
  • Labelling statements for various pharmaceuticals
Mean Kinetic Temperature (MKT) and World Climatic Zones/Uses and Misuses of MKT
  • Mean Kinetic Temperature (MKT) and relative humidity
  • Interpretation of MKT
  • MKT from temperature loggers
Stress Studies of Pharmaceuticals
  • Degradation reactions
  • Stressing factors and conditions
  • Stress studies in the pharmaceutical industry
Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals
  • Stress testing vs Forced Degradations
  • Studies at elevated extreme temperatures
  • Studies at low extreme conditions
  • When, how and what?
  • Thermal Cyclic studies
  • What attributes to test
Cycling Studies: Case Study

Excursions during Shipping and Distributions
  • “Time-out-of-Storage” and stability budget“ Concept
  • Handling an excursion
Investigating Excursions during Shipping and Distributions
  • What stability data are required to investigate temperature excursions
  • Responsibilities of manufacturer, distributor and QP
Video Presentations

Evaluation of the Impact of Temperature Excursions
  • Estimation of the impact by the excursion temperature on the quality Attribute
  • Estimation of the quality attribute at the end of shelflife/retest date
Handling of Excursions: Case Studies
 
Recording from 10/11 September 2025
Duration of the recording: approx. 7 h 30 min

stop

This course is part of the GMP Certification Programme "ECA Certified Quality Control Manager" Learn more

ECA-Member*: € 1890,-
Regular Fee*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025